Related Experiment Video
Updated: Sep 18, 2025

Segmentation and Measurement of Fat Volumes in Murine Obesity Models Using X-ray Computed Tomography
Published on: April 4, 2012
Diverse Obesity Trajectories in a Family Including Identical Twins with a Pathogenic MC4R Variant
Jane Jia Xin Lim1, Amanda J Hooper2,3, Joan Khoo4
1Department of Endocrinology, Changi General Hospital, Singapore, Singapore, jane.lim94@gmail.com.
Abstract:
Introduction: Pathogenic heterozygous melanocortin-4 receptor (MC4R) variants are the most common cause of monogenic obesity, affecting central satiety and appetite regulatory areas of the brain. Case Presentations: We report a pedigree with a pathogenic MC4R variant (c.380C>T, p.Ser127Leu). In the proband with obesity (BMI 35 kg/m2) and severe insulin resistance, use of combination of semaglutide and naltrexone-bupropion was successful in reducing insulin requirements and weight. His adult monozygotic twin daughters both had childhood-onset obesity; however, weight trajectories differed. Twin 1 had a peak BMI of 29.1 kg/m2, which decreased to 19.7 kg/m2 with intensive exercise and diet control without weight-lowering medication. Twin 2 had a sedentary lifestyle and epilepsy and had a peak BMI of 30.1 kg/m2; she responded well to naltrexone-bupropion and BMI decreased to 26 kg/m2. Conclusion: The manifestation of obesity, even in cases of monogenic obesity, can vary significantly due to the influence of environmental and lifestyle factors.
.Insights
Monogenic obesity caused by melanocortin-4 receptor (MC4R) variants can manifest differently. Lifestyle and environmental factors significantly influence obesity presentation and treatment response.
Area of Science:
- Genetics
- Endocrinology
- Obesity Research
Background:
- Pathogenic heterozygous melanocortin-4 receptor (MC4R) variants are a leading genetic cause of monogenic obesity.
- MC4R variants disrupt central appetite and satiety regulation in the brain.
Observation:
- A family (pedigree) presented with a pathogenic MC4R variant (c.380C>T, p.Ser127Leu).
- The proband, with obesity (BMI 35 kg/m2) and severe insulin resistance, showed improved weight and insulin sensitivity with semaglutide and naltrexone-bupropion.
- Monozygotic twin daughters exhibited distinct obesity trajectories despite sharing the MC4R variant; one achieved normal BMI through lifestyle changes, while the other required medication (naltrexone-bupropion) to manage obesity.
Findings:
- Obesity presentation and treatment response vary even with identical genetic predisposition (MC4R variant).
- Intensive lifestyle interventions (diet, exercise) can effectively manage obesity in some individuals with monogenic obesity.
- Pharmacological interventions (semaglutide, naltrexone-bupropion) show efficacy in managing obesity and related metabolic issues in MC4R variant carriers.
Implications:
- Environmental and lifestyle factors play a crucial role in modulating the phenotypic expression of monogenic obesity.
- Personalized treatment strategies considering genetic background and lifestyle are essential for effective obesity management.
- Understanding the interplay between genetics and environment is key to developing targeted therapies for obesity.
Related Concept Videos
Obesity
Pleiotropy
Polygenic Traits
Multiple Allele Traits
X-linked Traits
Animal Mitochondrial Genetics

